Continue reading this on our app for a better experience

Open in App
Home Capital Broker's Calls

DBS keeps 'buy' call but trims target price for Grand Venture Technology

The Edge Singapore
The Edge Singapore • 2 min read
DBS keeps 'buy' call but trims target price for Grand Venture Technology
Photo: Albert Chua
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

DBS Group Research has trimmed its target price of Grand Venture Technology, following its 1!FY2023 earnings that dropped by more than half over the year earlier quarter.

For the three months to March, GVT reported earnings of $1.5 million, down 58.3% y-o-y; revenue was down 17% y-o-y to $26.9 million. The drag was especially pronounced in GVT's semiconductor segment, as the worldwide industry grapples with a downturn.

"Notwithstanding near-term volatility, the semiconductor industry is well poised for growth, owing to the push towards digitalisation," states DBS analyst Ling Lee Keng in her May 12 note.

While she has kept her "buy" call, Ling has trimmed her target price to 56 cents from 60 cents, which is pegged to 12x forward FY2024 earnings.

CGS-CIMB's William Tng and Izabelle Tan, meanwhile, have maintained their "hold" call and 54 cents target price, even though the 1QFY203 earnings was below their expectations.

"We reiterate Hold, premised on the growth potential from new front-end semicon customers that GVT is pursuing," state the analysts in their May 11 note.

See also: DBS says S’pore T-bill holders are a ‘liquidity catalyst’ for S-REITs like Lendlease REIT, Keppel REIT

Their 54 cents target price is based on an unchanged 10.4x forward FY2024 earnings, which is 0.5 s.d. below its 3-year average.

Tng and Tan see downside risks to include a severe drop in customer orders if the world slips into a recession and higher-than-expected spending for long-term growth.

On the other hand, upside might come from potential new customer wins with significant purchase orders and accretive M&A. If so, they would raise GVT’s revenue over FY204 and FY2025, resulting in higher earnings.

Highlights

New IHH Healthcare CEO Nair lays out growth plans
Company in the news

New IHH Healthcare CEO Nair lays out growth plans

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.